Asia Pacific (APAC) Healthcare Sector Outlook: Opportunity and Demand Analysis, Market Forecast, 2016-2024

Pages : 460 | Category: | Publishers: Goldstein Research

Description

Asia Pacific (APAC) Healthcare Sector Outlook

Market Overview       

Strong economic rise in APAC region comes with benefit and challenges for the healthcare industry. In spite of rising hospitals, patients in rural as well as urban areas are still facing accessibility and affordability issues. Innovation in technology is resolving the challenges with digital enablement, for instance, GE Healthcare’s Sustainable Healthcare Solutions (SHS) are developing clinically and economically relevant technologies, providing skills training for medical personnel and financing solutions of funding for industry players. Similarly, Siemens Healthineers is utilizing artificial intelligence to interpret radiology images (X-ray, MRI and CT scans).

Inequity in Phillippines affects the healthcare sector, enabling Hospital Management Asia to enable solutions specific to digitization and information communication improvements in business, telemedicine and healthcare developments. Philippines make up about 45% out-of-pocket medical expenditure. Prescription drug however continue to dominate the market. Laws such as the Cheaper Medicines Act of 2008 and the Universal Healthcare Act of 2013 driving the growth potential of generic drug market, 5 out of 10 Filipinos use generic drugs. Dairy Farm International, a Hong Kong-based company, has entered the Philippine pharma market through its 49% stake in Rose Pharmacy.

In order to cost reduction of pharmaceuticals, Japanese government is introducing policies to expand the use of generic drugs. E-commerce regulations are becoming a dire need in countries like India owing to f 259.14 million Internet and broadband subscribers. New Long-term Care Services Act passed in Taiwan that will regulate the provision of care professionals for physically challenged or mentally impaired, living alone and unable to care for themselves.

Market Segmentation

By Type

  • Pharmaceuticals
  • Services
  • Devices (medical equipments)
  •  Others (reagents and disposables)

By Sector

  • Public
  • Private

By Application

  • Cardiovascular
  • Oncology
  • Anti-infection
  • CNS
  • Respiratory
  • Others (dermatology, dentistry, diabetes, etc)

By End User

  • Hospitals/clinics
  • Diagnostic Labs
  • Homecare Settings
  • Research and Development Centers

By Countries

  • China {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Japan {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • India {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Australia {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Taiwan {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • South Korea {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Indonesia {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Thailand {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Singapore {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • New Zealand {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
  • Philippines {Market Share (%), Market Size (USD Million), Adoption Rate (%)}

Market Size Outlook (2016-2024)

Total global healthcare expenditure valued USD 540 billion in 2016, which is projected to grow at a CAGR of 10% in developing economies. Healthcare expenditure for APAC nations valued USD 230 billion in 2016. Among all the APAC nations China accounts for second largest health expenditure revenue i.e. USD 85 billion in 2016 after Japan. Hospitals continue to be largest share holder of APAC healthcare market.

Total healthcare expenditure of Indonesia valued USD 27 billion and is expected to grow at the CAGR of 7.5% which tends to reach USD 40 billion by 2024.  Singapore is the world’s fourth best healthcare infrastructure with less than 5% of GDP spending on healthcare and providing multiple layers of care to each resident.

Growth Drivers & Challenges

Medical Tourism rising affluence, outpatient surgery lucrative business with less investment and more profit, increasing specialty hospitals, spiking in private medical insurance coverage and upgrading IT and healthcare operations tends to drive the APAC healthcare market. Pharmacies undergoing transformation with e-commerce, investments by major players, telecoms launch home health platforms, stronger regulations in favor of consumers and increasing mergers and acquisition in healthcare are the factors responsible for growing healthcare industry in APAC region.

Rise of chronic or non-communicable (NCD’s) diseases tend to put the strain on stretched healthcare system of APAC region. According to World Economic Forum, by the year 2030 cardiovascular disease (CVD), chronic respiratory disease, cancer, diabetes and mental ill-health will cost the global economy USD 47 trillion. In addition to that, limited financial resources, various consumer segments that create complexities, underdeveloped medical infrastructure, inconsistent reimbursement regimes and intense competition from major players in adjacent industries (high tech and consumer electronics) as well as from regional start ups hamper the APAC healthcare market.

Key Market Players

  • Siemens Healthcare
  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis
  • KPJ Healthcare Bhd
  • Raffles Medical Group
  • Apollo Hospitals Enterprise Ltd
  • Medtronic
  • Roche
  • Alere
  • GE Healthcare
  • B Braun
  • Abbott
  • MIRACA Holdings Inc
  • Concord Medical Services Holdings Limited
  • 3M
  • Allscripts
  • Mckesson
  • Orion Health
  • Oneview
  • Pulsesync
  • Ziosoft
  • Nuance Communications
  • Healint

Scope Background

Market Synopsis

Market Segmentation

The APAC Healthcare Market is segmented as follows:

  • By Type (Market Size, Demand Analysis and Growth Analysis)
  • By Sector (Market Size, Demand Analysis and Growth Analysis)
  • By Application (Market Size, Demand Analysis and Growth Analysis)
  • By End-User (Market Size, Demand Analysis and Growth Analysis)

By Countries

  • China {Market Size, Growth Analysis and Opportunity Analysis}
  • Japan {Market Size, Growth Analysis and Opportunity Analysis}
  • India {Market Size, Growth Analysis and Opportunity Analysis}
  • South Korea {Market Size, Growth Analysis and Opportunity Analysis}
  • Taiwan {Market Size, Growth Analysis and Opportunity Analysis}
  • Australia {Market Size, Growth Analysis and Opportunity Analysis}
  • New Zealand {Market Size, Growth Analysis and Opportunity Analysis}
  • Thailand {Market Size, Growth Analysis and Opportunity Analysis}
  • Philippines {Market Size, Growth Analysis and Opportunity Analysis}
  • Indonesia {Market Size, Growth Analysis and Opportunity Analysis}
  • Singapore {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

Key Market Players

  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks

Table of Contents
1. Executive Summary
2. Research Methodology
3. Regional Opportunity Analysis on the basis of Competitors
4. Asia Pacific (APAC) Healthcare Market Size (USD Billion) and Forecast Analysis, 2016-2024
5. Market Dynamics: Growth Drivers, Restraints and Opportunities
5.1. Risk Factors
5.2. Regional Variations
5.3. Recent Trends and Developments
6. Asia Pacific (APAC) Healthcare Market Segmentation
6.1. Asia Pacific (APAC) Healthcare Market By Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Adoption Rate (%)of Asia Pacific (APAC) Healthcare Market by Type
6.1.2. Pharmaceuticals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.3. Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.4. Devices (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.5. Others (reagents & disposables) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.6. Market Attractiveness of Asia Pacific (APAC) Healthcare Market by Type
6.1.7. BPS Analysis of Asia Pacific (APAC) Healthcare Market by Type
6.2. Asia Pacific (APAC) Healthcare Market By Sector (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.1. Adoption Rate (%)of Asia Pacific (APAC) Healthcare Market by Sector
6.2.2. Public Sector (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.3. Private Sector (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.4. Market Attractiveness of Asia Pacific (APAC) Healthcare Market by Sector
6.2.5. BPS Analysis of Asia Pacific (APAC) Healthcare Market by Sector
6.3. Asia Pacific (APAC) Healthcare Market By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1. Adoption Rate (%) Asia Pacific (APAC) Healthcare Market by Application
6.3.2. Cardiovascular (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3. Oncology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4. Anti-infection (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5. CNS (Central Nervous System) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.6. Respiratory (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.7. Others (dermatology, dentistry, diabetes, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.8. Market Attractiveness of Asia Pacific (APAC) Healthcare Market by Application
6.3.9. BPS Analysis Asia Pacific (APAC) Healthcare Market by Application
6.4. Asia Pacific (APAC) Healthcare Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.1. Adoption Rate (%) Asia Pacific (APAC) Healthcare Market by End Users
6.4.2. Hospital/Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.3. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.4. Homecare Settings (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.5. Research & Development Centers (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.6. Market Attractiveness of Asia Pacific (APAC) Healthcare Market by End Users
6.4.7. BPS Analysis Asia Pacific (APAC) Healthcare Market by End Users
6.5. Asia Pacific (APAC) Healthcare Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.1. Adoption Rate (%) Asia Pacific (APAC) Healthcare Market by Country
6.5.2. China Healthcare Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3. Japan Healthcare Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4. India Healthcare Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5. Australia Healthcare Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.6. New Zealand Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.7. Singapore Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.8. Thailand Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.9. South Korea Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.10. Indonesia Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.11. Taiwan Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.12. Philippines Healthcare Market ((Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.13. Market Attractiveness of Asia Pacific (APAC) Healthcare Market by Country
6.5.14. BPS Analysis Asia Pacific (APAC) Healthcare Market by Country
7. Competitive Outlook
7.1. Market Share of Major Players (2016)
7.2. Company Profiles
7.2.1. Siemens Healthcare
7.2.1.1. Company Synopsis
7.2.1.2. Business Strategy
7.2.1.3. Product Portfolio
7.2.1.4. SWOT Analysis
7.2.2. KPJ Healthcare Bhd
7.2.3. Raffles Medical Group
7.2.4. Apollo Hospitals Enterprise Ltd
7.2.5. Medtronic
7.2.6. Roche
7.2.7. Alere
7.2.8. GE Healthcare
7.2.9. B Braun
7.2.10. Abbott
7.2.11. MIRACA Holdings Inc
7.2.12. Concord Medical Services Holdings Limited
7.2.13. 3M
7.2.14. Allscripts
7.2.15. Mckesson
7.2.16. Orion Health
7.2.17. Oneview
7.2.18. Pulsesync
7.2.19. Ziosoft
7.2.20. Nuance Communications
7.2.21. Healint
8. Porter’s Five Force Model
9. Market Landscape: Competition and Beyond
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
11. Expert Analysis
12. Concluding Remarks


SELECT LICENSE TYPE